Fundz

Episteme Prognostics, Inc. reported raising $4.11 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEJan 03, 2022

Amount Raised

$4.11 Million

$4.11 Million sold, per SEC Form D (first sale Jan 3, 2022)

Round Type

Pre-Seed

New YorkBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Episteme Prognostics that raised within 45 days of this round, from Fundz verified event records.

  • Synthego Corp raised $200M (Funding Round) on February 17, 2022.
  • Confluent Medical raised an undisclosed amount on February 17, 2022.
  • Seer raised $15M (Series B) on February 17, 2022.
  • Neo Medical raised $21M (Funding Round) on February 17, 2022.
  • Classiq raised $33M (Funding Round) on February 17, 2022.
  • Rubi Laboratories raised $4.5M (Seed) on February 17, 2022.

Who to call at Episteme Prognostics, and when

A new round usually means Episteme Prognostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Episteme Prognostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Episteme Prognostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Episteme Prognostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Episteme Prognostics

Location

760 Parkside Avenue

New York, New York, United States

About

Episteme Prognostics is a precision medicine company that develops therapeutic biomarkers for pancreatic cancer. It predicts chemotherapy response and assesses the benefit of epigenetic therapy to pancreatic cancer patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Episteme Prognostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsSurajit D., Founder, President & CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Episteme Prognostics's next move

See what Strategic adds

Episteme Prognostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.